Advanced Search

Journal of Traditional Chinese Medicine >

2022 , Vol. 42 >Issue 6: 932 - 939

DOI: https://doi.org/10.19852/j.cnki.jtcm.20220815.004

Research Articles

Shikonin alleviates collagen-induced arthritis mice by inhibiting M1 macrophage polarization

  • Lianhua HE ,
  • Huijie LUAN ,
  • Qingxia QIN ,
  • Juan HE ,
  • Jian CHEN ,
  • Yiping HU ,
  • Yueming CAI ,
  • Desheng SUN ,
  • Yu SHI ,
  • Qingwen WANG
Expand
  • 1 Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen 518036, China; Shenzhen China Resources Sanjiu Pharmaceutical Trading Co., Ltd., Shenzhen 518029, China
    2 Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen 518036, China. The Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen 518036, China
    3 Department of ultrasound, Peking University Shenzhen Hospital, Shenzhen 518036, China
Prof. WANG Qingwen, Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen 518036, China. wqw_sw@163.com,Telephone: +86-13688802429; +86-13823578405
SHI Yu, Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen 518036, China. shiyu@pkuszh.com;

Received date: 2021-11-13

  Accepted date: 2022-01-21

  Online published: 2022-08-15

Supported by

Role and Mechanism of Ermiao San in the Regulation of Th cell Differentiation by PKC-ɵ in the Treatment of RA(20211333);Role and Mechanism of CD4+T Cell Smad7 Loss in the Pathogenesis of Rheumatoid Arthritis(81974253);Significance of Regulating Glycolytic Metabolism by HK-2 in Dendritic Cell Migration and RA Pathogenesis(81901641);Research on Key Technologies of Intelligent Robot Based on Artificial Intelligence Image Data(GJHZ20200731095208025);Virtual Reality Clinical Application Public Service Platform(XMHT20190104001);Biological Markers in Idiopathic Inflammatory Myopathy and Clinical Significance of Tumorigenesis(SZXJ2017046);Experimental Study on Treatment of Rabbit Rheumatoid Arthritis with Lipidated Methotrexate Microbubbles Combined with Controlled Release by Ultrasonic Irradiation(2018A030313281)

Fold

Abstract

OBJECTIVE: To investigate the effects of shikonin (SKN) on M1 and M2 polarization of macrophages both in vitro and in vivo.

METHODS: Collagen-induced arthritis (CIA) in male DBA/1 mice were treated with a dose of 4 mg/kg/day of SKN for 23 d (n = 6/group). The histopathology of inflamed joints in CIA mice was evaluated to test the anti-arthritic effect of SKN. M1/M2 polarization of macrophages induced by lipopolysaccharide (LPS) and interferon (IFN)-γ or interleukin (IL)-4 and IL-13, were used to assess the effect of SKN (0.05, 0.1, and 0.2 μM). The effect of SKN on the protein expression of nitric oxide synthase, arginase, CD68, and CD206 was evaluated using western blot analysis.

RESULTS: The results of this study revealed that SKN delayed the arthritis feet symptom score, reduced the incidence rate of arthritis, and relieved the inflammation of joints in CIA mice. SKN inhibited M1 macrophage polarization but did not affect M2 macrophage polarization in the joints of CIA mice. Moreover, SKN inhibited M1 polarization induced by LPS and IFN-γ, but did not affect M2 polarization induced by IL-4 and IL-13.

CONCLUSION: These findings suggest that SKN alleviated CIA through inhibiting M1 macrophage polarization and has great potential as a new drug for RA treatment.

Key words： Shikonin; arthritis, rheumatoid; macrophages; M1 polarization

Cite this article

Lianhua HE , Huijie LUAN , Qingxia QIN , Juan HE , Jian CHEN , Yiping HU , Yueming CAI , Desheng SUN , Yu SHI , Qingwen WANG . Shikonin alleviates collagen-induced arthritis mice by inhibiting M1 macrophage polarization[J]. Journal of Traditional Chinese Medicine, 2022 , 42(6) : 932 -939 . DOI: 10.19852/j.cnki.jtcm.20220815.004

References

[1] Andújar I, Ríos JL, Giner RM, Recio MC. Pharmacological properties of shikonin - a review of literature since 2002. Planta Med 2013; 79: 1685-97.
[2] Wang F, Yao X, Zhang Y, Tang J. Synthesis, biological function and evaluation of shikonin in cancer therapy. Fitoterapia 2019; 134: 329-39.
[3] Dai Q, Fang J, Zhang FS. Dual role of shikonin in early and late stages of collagen type II arthritis. Mol Biol Rep 2009; 36: 1597-604.
[4] Lee CC, Wang CN, Lai YT, et al. Shikonin inhibits maturation of bone marrow-derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma. Br J Pharmacol 2010; 161: 1496-511.
[5] Kim YO, Hong SJ, Yim SV. The efficacy of shikonin on cartilage protection in a mouse model of rheumatoid arthritis. Korean J Physiol Pharmacol 2010; 14: 199-204.
[6] Tardito S, Martinelli G, Soldano S, et al. Macrophage M1/M2 polarization and rheumatoid arthritis: a systematic review. Autoimmun Rev 2019; 18: 102397.
[7] Yuan DP, Gu L, Long J, et al. Shikonin reduces endometriosis by inhibiting RANTES secretion and mononuclear macrophage chemotaxis. Exp Ther Med 2014; 7: 685-90.
[8] Koike A, Shibano M, Mori H, Kohama K, Fujimori K, Amano F. Simultaneous addition of shikonin and its derivatives with lipopolysaccharide induces rapid macrophage death. Pharm Bull 2016; 39: 969-76.
[9] Remmers EF, Joe B, Griffiths MM, et al. Modulation of multiple experimental arthritis models by collagen-induced arthritis quantitative trait loci isolated in congenic rat lines: different effects of non-major histocompatibility complex quantitative trait loci in males and females. Arthritis Rheum 2002; 46: 2225-34.
[10] Prado C, Ugalde V, González H, et al. STAT3 activation in combination with NF-KappaB inhibition induces tolerogenic dendritic cells with high therapeutic potential to attenuate
[11] He LH, Qin QX, He J, et al. ErMiao San inhibits angiogenesis in rheumatoid arthritis by suppressing JAK/STAT signaling path-ways. Evid Based Complement Alternat Med 2020; 2020: 1-12.
[12] He L, Liu C, Sun C, et al. Wu-Tou Decoction inhibits angiogenesis in experimental arthritis by targeting VEGFR2 signaling pathway. Rejuvenation Res 2018; 21: 442-55.
[13] Liu CF, Kong XY, Li XB, et al. Wen Luo Yin inhibits angiogenesis in collagen-induced arthritis rat model and in vitro. J Ethnopharmacol 2013; 149: 478-89.
[14] Liu CF, He LH, Wang JX, et al. Anti-angiogenic effect of shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways. J Ethnopharmacol 2020; 260: 113039.
[15] He LH, Luan HJ, He J, et al. Shikonin attenuates rheumatoid arthritis by targeting SOCS1/JAK/STAT signaling pathway of fibroblast like synoviocytes. Chin Med 2021; 16: 96.
[16] Ying W, Cheruku PS, Bazer FW, Safe SH, Zhou B. Investigation of macrophage polarization using bone marrow derived macrophages. J Vis Exp 2013; 50323.
[17] Burke B, Giannoudis A, Corke KP, et al. Hypoxia-induced gene ex-pression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 2003; 163: 1233-43.
[18] Viatte S, Plant D, Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nature reviews. Rheumatol 2013; 9: 141-53.
[19] McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-19.
[20] Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granu-locyte macro-phage colony-stimulating factor production by rh-eumatoid arthritis synoviocytes. J Clin Invest 1990; 86: 1790-8.
[21] Athanasou NA, Quinn J, Heryet A, Puddle B, Woods CG, McGee JO. The immunohistology of synovial lining cells in normal and inflamed synovium. J Pathol 1988; 155: 133-42.
[22] Bondeson J, Blom AB, Wainwright S, Hughes C, Caterson B, van den Berg WB. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010; 62: 647-57.
[23] Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 2000; 43: 1244-56.
[24] Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008; 118: 3537-45.
[25] Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
[26] Kishimoto T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu Rev Immunol 2005; 23: 1-21.
[27] Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344: 907-16.
[28] Bresnihan B, Gerlag DM, Rooney T, et al. Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. J Rheumatol 2007; 34: 620-2.
[29] Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996; 39: 115-24.
[30] Haringman JJ, Gerlag DM, Zwinderman AH, et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in pa-tients with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 834-8.
[31] Gordon S. The macrophage: past, present and future. Eur J Immunol 2007; 37 Suppl 1: S9-17.
[32] Falconer J, Murphy AN, Young SP, et al. Review: synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis Rheum 2018; 70: 984-99.
[33] Mantovani A, Sica A, Sozzani S, AllavenaP, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-86.
[34] Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nature reviews. Immunology 2008; 8: 533-44.
Options
Outlines

/

〈 〉